Infinion Biopharma Plans Rs. 100-cr. capex for Innovative Healthcare Technologie

Technology start-up, Infinion Biopharma – set up by two NRI healthcare professionals – plans to invest Rs. 100-crore towards developing innovative technologies in healthcare. It plans to set up a manufacturing and research facility in India. The company looks to develop innovative technologies for key therapeutic areas of diabetes, women healthcare, drug delivery in pain and infection.

“We are currently scouting for suitable location in Ahmedabad or in Bengaluru. We primarily focus on developing new, economical and proprietary treatment options and technologies. We will raise the required funds from the promoters and other individual sources,” said Mr. Vishal Jain, President & CEO, who is also one of the two promoters of the company.

The company is involved in developing a range of economical and proprietary treatment options for various indications including cancer, inflammatory disorders and diabetes. Infinion Biopharrma will patent the processes and products and plans to licence it out to drug makers. It also plans to enter the consumer segment by launching products.

The company is also developing localised, biodegradable drug-delivery technologies aimed at enhancing efficacy and reducing adverse side-effects with duration ranges of 7-10 days for surgical site infection and acute pain indications. “Our strength is our ability to effectively combine various disciplines including immuno-therapy, material science, biochemistry and physics,” added Mr. Jain.